Literature DB >> 18381096

Oral iron chelators.

Janet L Kwiatkowski1.   

Abstract

Effective chelation therapy can prevent or reverse organ toxicity related to iron overload, yet cardiac complications and premature death continue to occur, largely related to difficulties with compliance in patients who receive parenteral therapy. The use of oral chelators may be able to overcome these difficulties and improve patient outcomes. A chelator's efficacy at cardiac and liver iron removal and side-effect profile should be considered when tailoring individual chelation regimens. Broader options for chelation therapy, including possible combination therapy, should improve clinical efficacy and enhance patient care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381096     DOI: 10.1016/j.pcl.2008.01.005

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  2 in total

Review 1.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

2.  Model-Based Optimisation of Deferoxamine Chelation Therapy.

Authors:  Francesco Bellanti; Giovanni C Del Vecchio; Maria C Putti; Carlo Cosmi; Ilaria Fotzi; Suruchi D Bakshi; Meindert Danhof; Oscar Della Pasqua
Journal:  Pharm Res       Date:  2015-11-10       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.